Kelsey Goodwin

Kelsey Goodwin is currently a Senior Analyst in Biotech Equity Research at Piper Sandler, a position held since June 2025. Prior experience includes serving as a Vice President, Senior Associate, and Biotechnology Equity Research Associate at Guggenheim Partners from July 2018 to June 2025. Kelsey also worked at IQVIA as a Consultant and Associate Consultant between October 2016 and July 2018, and held the role of Analyst at The Amundsen Group, an IMS Health company, from August 2015 to October 2016. Additionally, Kelsey gained research experience as an Immunology Research Intern at Harvard Medical School in the summer of 2014. Kelsey completed an undergraduate degree at Bowdoin College from 2011 to 2015 and studied abroad at The University of Queensland in 2013.